A double-blind parallel study of tenoxicam and piroxicam in patients with osteoarthrosis
Bird, H.A.; Hill, J.; Dixon, J.S.; Looi, D.; Wright, V.
European Journal of Rheumatology and Inflammation 8(1): 53-59
1985
ISSN/ISBN: 0140-1610 PMID: 3915888 Document Number: 259587
Tenoxicam (TILCOTIL, MOBIFLEX) 40 mg/day has been compared to piroxicam 40 mg/day in a double-blind, parallel group study of 4 weeks duration in 30 patients with osteoarthrosis. Both drugs were well tolerated, tenoxicam slightly better than piroxicam. Both drugs improved general pain, improvement being greater with tenoxicam. Little improvement of other symptoms was seen with either treatment. At the end of the study, 12 tenoxicam-treated patients and seven piroxicam-treated patients elected to remain on their respective treatment.
Document emailed within 1 workday
Related Documents
Battagliotti, C.A.; Baetti, E.A. 1987: Clinical, double-blind long-term study of tenoxicam 20 mg (Ro 12-0068) versus piroxicam 20 mg in patients with gonarthrosis European Journal of Rheumatology and Inflammation 9(2): 74-76Moser, U.; Waldburger, M.; Schwarz, H.A.; Gobelet, C.A. 1989: Double-blind randomized multicenter study with tenoxicam, piroxicam and diclofenac sodium retard in the treatment of ambulatory patients with arthroses and soft tissue rheumatism Schweizerische Rundschau für Medizin Praxis 78(10): 263-269
Adelowo, O.O.; Chukwuani, C.M.; Grange, J.J.; Ojeasebhulo, E.E.; Onabowale, B.O. 1998: Comparative double blind study of the efficacy and safety of tenoxicam vs. piroxicam in osteoarthritis of knee and hip joints West African Journal of Medicine 17(3): 194-198
Giro, C.; Lo Presti, R. 1979: Double-blind comparative study of indoprofen and ibuprofen in patients with osteoarthrosis Giornale di Clinica Medica 60(1): 65-71
Zhao, S.; Wang, F.; Yang, K.; Hao, Y.; Li, G.; Yang, M.; Yang, Z. 2014: Efficacy and safety of fluvastatin extended-release tablets in Chinese patients with hyperlipidemia: a multi-center, randomized, double-blind, double dummy, active-controlled, parallel-group study Zhonghua Nei Ke Za Zhi 53(6): 455-459
Caroli, A. 1980: Double-blind study of SAMe (capsules) and aspirin in osteoarthrosis Giornale di Clinica Medica 61(11): 844-857
Perpignano, G.; Bogliolo, A.; Puccetti, L. 1994: Double-blind comparison of the efficacy and safety of etodolac SR 600 mg u.i.d. and of tenoxicam 20 mg u.i.d. in elderly patients with osteoarthritis of the hip and of the knee International Journal of Clinical Pharmacology Research 14(5-6): 203-216
Müller, P.; Dammann, H.G.; Marinis, E.; Simon, B. 1989: Gastroduodenal tolerance of tenoxicam versus diclofenac-Na: an endoscopy double-blind controlled study in healthy probands Zeitschrift für Rheumatologie 48(5): 243-245
Fahy, G.; Deb, B.; Robinson, K.; Graham, I. 1993: The effects of lisinopril on serum catecholamine concentrations both at rest and on exercise in patients with congestive cardiac failure. a double blind, placebo controlled, parallel group study Irish Medical Journal 86(4): 134-135
Lacey, P.H.; Dodd, G.D.; Shannon, D.J. 1984: A double blind, placebo controlled study of piroxicam in the management of acute musculoskeletal disorders European Journal of Rheumatology and Inflammation 7(3): 95-104
Riedemann, P.J.; Bersinic, S.; Cuddy, L.J.; Torrance, G.W.; Tugwell, P.X. 1993: A study to determine the efficacy and safety of tenoxicam versus piroxicam, diclofenac and indomethacin in patients with osteoarthritis: a meta-analysis Journal of Rheumatology 20(12): 2095-2103
Webster, G.F.; Leyden, J.J.; Gross, J.A. 2014: Results of a Phase III, double-blind, randomized, parallel-group, non-inferiority study evaluating the safety and efficacy of isotretinoin-Lidose in patients with severe recalcitrant nodular acne Journal of Drugs in Dermatology: Jdd 13(6): 665-670
Martínez-Cócera, C.; De Molina, M.; Martí-Guadaño, E.; Pola, J.; Conde, J.; Borja, J.; Pérez, I.; Arnaiz, E.; Izquierdo, I. 2005: Rupatadine 10 mg and cetirizine 10 mg in seasonal allergic rhinitis: a randomised, double-blind parallel study Journal of Investigational Allergology and Clinical Immunology 15(1): 22-29
Müller, P.; Leucht, U.; Simon, B. 1992: High-dose ranitidine protects stomach and duodenum completely against piroxicam. An endoscopic double-blind pilot study Zeitschrift für Gastroenterologie 30(12): 851-853
Roy, V.; Gupta, U.; Sharma, S.; Dhaon, B.K.; Singh, N.P.; Gulati, P. 1999: Comparative efficacy and tolerability of nimesulide and piroxicam in osteoarthritis with specific reference to chondroprotection: a double blind randomised study Journal of the Indian Medical Association 97(10): 442-445
Pagano, M.; Sapienza, M.; Fuschi, C.; Nardi, I. 1985: Double blind comparison between imidazole-2-hydroxybenzoate and diclofenac sodium in the treatment of osteoarthrosis in geriatric patients Bollettino Chimico Farmaceutico 124(8): 108S-112S
Di Perri, T.; Auteri, A.; Caruso, I.; Corvetta, A.; Danieli, G.; Sarzi Puttini, P.C.; Scaricabarozzi, I. 1987: Multicenter double-blind randomized clinical trial of imidazole salicylate versus ibuprofen in patients with osteoarthrosis International Journal of Clinical Pharmacology Therapy and Toxicology 25(9): 479-482
Del Vecchio, L.; Pozzi, M.; Salvetti, A.; Maschio, G.; Fusaroli, M.; Rovati, C.; Antonucci, F.; Cascone, C.; Scanferla, F.; Panichi, V.; Sturani, A.; Locatelli, F. 2004: Efficacy and tolerability of manidipine in the treatment of hypertension in patients with non-diabetic chronic kidney disease without glomerular disease. Prospective, randomized, double-blind study of parallel groups in comparison with enalapril Journal of Nephrology 17(2): 261-269
Martí, M.L.; De los Santos, A.R.; Di Girolamo, G.; Gil, M.; Manero, E.O.; Fraga, C. 1993: Lysine clonixinate in minor dental surgery: double-blind randomized parallel study versus paracetamol International Journal of Tissue Reactions 15(5): 207-213
Vintró Molins, C.; Viaplana Más, J.M. 1985: Parallel double-blind clinical trial of nifedipine versus a placebo in patients with chronic cerebrovascular insufficiency Medicina Clinica 84(8): 308-311